Regulatory News
Monday, May 16, 2016
BRIEF-Pluristem completes enrollment of 150 patients in phase II intermittent claudication trial
* Pluristem completes enrollment of 150 patients in phase ii
intermittent claudication trial
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment